Literature DB >> 32584593

Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.

Devan Kansagara1, Katherine Mackey1, Kathryn Vela1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32584593      PMCID： PMC7322811          DOI： 10.7326/L20-0887

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.

Authors:  Yuchen Chen; Dong Yang; Biao Cheng; Jian Chen; Anlin Peng; Chen Yang; Chong Liu; Mingrui Xiong; Aiping Deng; Yu Zhang; Ling Zheng; Kun Huang
Journal:  Diabetes Care       Date:  2020-05-14       Impact factor: 19.112

2.  Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study.

Authors:  Sun-Young Jung; Jae Chol Choi; Seung-Hun You; Won-Young Kim
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

3.  Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review.

Authors:  Katherine Mackey; Valerie J King; Susan Gurley; Michael Kiefer; Erik Liederbauer; Kathryn Vela; Payten Sonnen; Devan Kansagara
Journal:  Ann Intern Med       Date:  2020-05-15       Impact factor: 25.391

4.  Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.

Authors:  Mandeep R Mehra; Sapan S Desai; SreyRam Kuy; Timothy D Henry; Amit N Patel
Journal:  N Engl J Med       Date:  2020-06-04       Impact factor: 91.245

5.  Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).

Authors:  Neil Mehta; Ankur Kalra; Amy S Nowacki; Scott Anjewierden; Zheyi Han; Pavan Bhat; Andres E Carmona-Rubio; Miriam Jacob; Gary W Procop; Susan Harrington; Alex Milinovich; Lars G Svensson; Lara Jehi; James B Young; Mina K Chung
Journal:  JAMA Cardiol       Date:  2020-09-01       Impact factor: 14.676

6.  The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.

Authors:  Zheyong Huang; Jiatian Cao; Yumeng Yao; Xuejuan Jin; Zhe Luo; Yuan Xue; Chouwen Zhu; Yanan Song; Ying Wang; Yunzeng Zou; Juying Qian; Kaihuan Yu; Hui Gong; Junbo Ge
Journal:  Ann Transl Med       Date:  2020-04
  6 in total
  3 in total

Review 1.  [COVID-19 and the kidneys].

Authors:  H Rohn; T Feldkamp; O Witzke
Journal:  Nephrologe       Date:  2020-06-26

2.  Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic.

Authors:  Ahmad A Alamer; Abdulaziz S Almulhim; Ahmed A Alrashed; Ivo Abraham
Journal:  Healthcare (Basel)       Date:  2021-01-28

Review 3.  Past, present and future of living systematic review: a bibliometrics analysis.

Authors:  Qingyong Zheng; Jianguo Xu; Ya Gao; Ming Liu; Luying Cheng; Lu Xiong; Jie Cheng; Mengyuan Yuan; Guoyuan OuYang; Hengyi Huang; Jiarui Wu; Junhua Zhang; Jinhui Tian
Journal:  BMJ Glob Health       Date:  2022-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.